Vanguard Group Inc. Has $2.30 Billion Stock Position in Astera Labs, Inc. $ALAB

Vanguard Group Inc. boosted its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 0.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,827,506 shares of the company’s stock after acquiring an additional 84,365 shares during the period. Vanguard Group Inc. owned 0.08% of Astera Labs worth $2,300,344,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Assetmark Inc. boosted its stake in shares of Astera Labs by 374.1% in the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after purchasing an additional 101 shares during the last quarter. Hilltop National Bank raised its stake in Astera Labs by 100.0% during the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after buying an additional 100 shares during the last quarter. Aventura Private Wealth LLC bought a new position in Astera Labs during the fourth quarter worth $33,000. National Bank of Canada FI lifted its holdings in Astera Labs by 159.0% in the third quarter. National Bank of Canada FI now owns 202 shares of the company’s stock valued at $39,000 after buying an additional 124 shares during the period. Finally, Wexford Capital LP acquired a new position in Astera Labs in the third quarter valued at $39,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Trading Up 7.4%

Shares of NASDAQ:ALAB opened at $196.85 on Thursday. The stock has a market cap of $33.72 billion, a PE ratio of 161.35, a price-to-earnings-growth ratio of 3.87 and a beta of 1.78. The stock’s fifty day simple moving average is $137.76 and its two-hundred day simple moving average is $153.10. Astera Labs, Inc. has a 1-year low of $62.31 and a 1-year high of $262.90.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.51 by $0.07. The firm had revenue of $270.58 million during the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The business’s revenue was up 91.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, sell-side analysts forecast that Astera Labs, Inc. will post 1.48 earnings per share for the current fiscal year.

Insider Activity

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of the stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $107.61, for a total value of $19,692,630.00. Following the completion of the sale, the director owned 319,863 shares in the company, valued at approximately $34,420,457.43. This trade represents a 36.39% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,757 shares of Astera Labs stock in a transaction that occurred on Monday, April 20th. The stock was sold at an average price of $175.12, for a total transaction of $657,925.84. Following the transaction, the director directly owned 67,144 shares in the company, valued at approximately $11,758,257.28. This represents a 5.30% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 1,064,888 shares of company stock valued at $150,764,723. 12.50% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the company. Loop Capital started coverage on Astera Labs in a report on Thursday, March 5th. They set a “buy” rating and a $250.00 price target for the company. UBS Group began coverage on Astera Labs in a research note on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 price objective on the stock. Barclays set a $165.00 target price on Astera Labs in a research report on Thursday, January 15th. Citigroup began coverage on Astera Labs in a research note on Thursday, April 2nd. They set a “buy” rating and a $200.00 target price for the company. Finally, Weiss Ratings lowered Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday, February 23rd. Fifteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $199.74.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.